13260-1-AP

antibody from Proteintech Group

Targeting: MR1 HLALS

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

13260-1-AP

Provider

Proteintech Group

Product name

MR1 antibody

Antibody type

Polyclonal

Description

MR1 antibody (Cat. #13260-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Mutations outside the MR1 antigen binding groove differentially inhibit presentation of exogenous antigens.

Kulicke CA, Lemon C, Krawic JR, Nieto Ramirez LM, Kim SJ, Narayanan G, Tafesse FG, Hildebrand WH, Dobos KM, Lewinsohn DM
The Journal of biological chemistry 2026 Apr;302(4):111317

---

Mutations outside the MR1 antigen binding groove differentially inhibit presentation of exogenous antigens.

Kulicke CA, Lemon C, Krawic JR, Ramirez LMN, Kim SJ, Narayanan G, Tafesse FG, Hildebrand WH, Dobos KM, Lewinsohn DM
bioRxiv : the preprint server for biology 2025 May 19;

---

Opposite effects of sevoflurane at high and low concentration on the airway inflammation in juvenile asthma rats: A TMT-based proteomics analysis study.

Wang FL, Zhou YN, Zhang GT, Ran Y, Yang XX, Zhou L, Zhu ZQ, Zhang Y, Liu DX
International immunopharmacology 2025 Jan 27;146:113922

---

Topical antibiotics limit depigmentation in a mouse model of vitiligo.

Touni AA, Sohn R, Cosgrove C, Shivde RS, Dellacecca ER, Abdel-Aziz RTA, Cedercreutz K, Green SJ, Abdel-Wahab H, Le Poole IC
Pigment cell & melanoma research 2024 Sep;37(5):583-596

---

MR1 Gene and Protein Expression Are Enhanced by Inhibition of the Extracellular Signal-Regulated Kinase ERK.

Constantin D, Nosi V, Kehrer N, Vacchini A, Chancellor A, Contassot E, Beshirova A, Prota G, Navarini A, Mori L, De Libero G
Cancer immunology research 2024 Oct 1;12(10):1452-1467

---

The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation.

Kulicke CA, De Zan E, Hein Z, Gonzalez-Lopez C, Ghanwat S, Veerapen N, Besra GS, Klenerman P, Christianson JC, Springer S, Nijman SM, Cerundolo V, Salio M
The Journal of biological chemistry 2022 Feb;298(2):101542

---

Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens.

Valestrand L, Zheng F, Hansen SH, Øgaard J, Hov JR, Björkström NK, Karlsen TH, Jiang X, Melum E
The American journal of pathology 2022 Apr;192(4):629-641

---

Ligand-dependent downregulation of MR1 cell surface expression.

Salio M, Awad W, Veerapen N, Gonzalez-Lopez C, Kulicke C, Waithe D, Martens AWJ, Lewinsohn DM, Hobrath JV, Cox LR, Rossjohn J, Besra GS, Cerundolo V
Proceedings of the National Academy of Sciences of the United States of America 2020 May 12;117(19):10465-10475

---

Lepidium meyenii Walpers polysaccharide and its cationic derivative re-educate tumor-associated macrophages for synergistic tumor immunotherapy.

Guo T, Yang Y, Gao M, Qu Y, Guo X, Liu Y, Cui X, Wang C
Carbohydrate polymers 2020 Dec 15;250:116904